What does APOTHEEK DE LINDE do?

APOTHEEK DE LINDE is a pharmacy in Retie. Public Limited, started on 21 December 1984, 1 establishment.

What is the address of APOTHEEK DE LINDE?

The registered office of APOTHEEK DE LINDE is located at Markt 2, 2470 Retie.

Is APOTHEEK DE LINDE still active?

Yes. According to the CBE (30 October 2026) APOTHEEK DE LINDE is active, legal situation “Normale toestand”, started on 21 December 1984.

Is APOTHEEK DE LINDE registered on Peppol?

Yes, APOTHEEK DE LINDE is registered on the Peppol network with ID 0208:0426637474.

What is the enterprise number of APOTHEEK DE LINDE?

The enterprise number of APOTHEEK DE LINDE is BE0426637474.

When was APOTHEEK DE LINDE founded?

APOTHEEK DE LINDE was founded on 21 December 1984.

Who are the directors of APOTHEEK DE LINDE?

According to the 2025 annual accounts, the directors of APOTHEEK DE LINDE are: Mapant BV, Charlie BV.

Is APOTHEEK DE LINDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 1984; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK DE LINDE make in 2025?

APOTHEEK DE LINDE posted a profit after taxes of € 40,346 in financial year 2025.

What is the revenue of APOTHEEK DE LINDE?

As a small company, APOTHEEK DE LINDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 109,540.

How many employees does APOTHEEK DE LINDE have?

According to the 2025 annual accounts, APOTHEEK DE LINDE has 0 full-time equivalents (FTE).

APOTHEEK DE LINDE (Public Limited) - Retie - BE0426637474

Dossier APOTHEEK DE LINDE, printed on 30 October 2026 from databakkes.be/en/0426637474/apotheek-de-linde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK DE LINDE from Retie, company number BE0426637474, closed financial year 2025 with a result of € 40,346 after tax. For that financial year APOTHEEK DE LINDE recorded a gross margin of € 109,540 and equity of € 78,956. Compared with financial year 2024, the result moved from € 45,156 to € 40,346. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 8, 2026.

What it is worth Growing

€ 78,956

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 40,346

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 61,319

▼ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,300 paid out

100 % of the profit went to the shareholders, mostly to MAPANT (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 100

▼ 60% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 291,587

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 292,636

▼ 9% vs 2024

€ 31,599 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 127,858

▲ 84% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 88,531 Gross margin 2022: € 88,531 First fiscal year in the series	€ 111,142 Gross margin 2023: € 111,142 ▲ 26% vs 2022 (€ 88,531) Favourable step	€ 105,737 Gross margin 2024: € 105,737 ▼ 5% vs 2023 (€ 111,142) Unfavourable step	€ 109,540 Gross margin 2025: € 109,540 ▲ 4% vs 2024 (€ 105,737) Favourable step	▲ 4%
Profit after taxes	€ 65,020 Profit after taxes 2022: € 65,020 First fiscal year in the series	€ 96,579 Profit after taxes 2023: € 96,579 ▲ 49% vs 2022 (€ 65,020) Favourable step	€ 45,156 Profit after taxes 2024: € 45,156 ▼ 53% vs 2023 (€ 96,579) Unfavourable step	€ 40,346 Profit after taxes 2025: € 40,346 ▼ 11% vs 2024 (€ 45,156) Unfavourable step	▼ 11%
Equity	€ 78,675 Equity 2022: € 78,675 First fiscal year in the series	€ 78,754 Equity 2023: € 78,754 Unchanged (€ 78,675) Favourable step	€ 78,910 Equity 2024: € 78,910 Unchanged (€ 78,754) Favourable step	€ 78,956 Equity 2025: € 78,956 Unchanged (€ 78,910) Favourable step
Total debts	€ 296,612 Total debts 2022: € 296,612 First fiscal year in the series	€ 216,114 Total debts 2023: € 216,114 ▼ 27% vs 2022 (€ 296,612) Favourable step	€ 607,560 Total debts 2024: € 607,560 ▲ 181% vs 2023 (€ 216,114) Unfavourable step	€ 599,009 Total debts 2025: € 599,009 ▼ 1% vs 2024 (€ 607,560) Favourable step	▼ 1%
Cash	€ 68,962 Cash 2022: € 68,962 First fiscal year in the series	€ 38,421 Cash 2023: € 38,421 ▼ 44% vs 2022 (€ 68,962) Unfavourable step	€ 97,656 Cash 2024: € 97,656 ▲ 154% vs 2023 (€ 38,421) Favourable step	€ 61,319 Cash 2025: € 61,319 ▼ 37% vs 2024 (€ 97,656) Unfavourable step	▼ 37%
Retained profit	€ 16,675 Retained profit 2022: € 16,675 First fiscal year in the series	€ 16,754 Retained profit 2023: € 16,754 Unchanged (€ 16,675) Favourable step	€ 16,910 Retained profit 2024: € 16,910 ▲ 1% vs 2023 (€ 16,754) Favourable step	€ 16,956 Retained profit 2025: € 16,956 Unchanged (€ 16,910) Favourable step
Dividend	€ 64,500 Dividend 2022: € 64,500 First fiscal year in the series	€ 96,500 Dividend 2023: € 96,500 ▲ 50% vs 2022 (€ 64,500) Unchanged	€ 45,000 Dividend 2024: € 45,000 ▼ 53% vs 2023 (€ 96,500) Unchanged	€ 40,300 Dividend 2025: € 40,300 ▼ 10% vs 2024 (€ 45,000) Unchanged	▼ 10%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 323,077 Bank debt 2024: € 323,077 Unchanged (€ 0) Unfavourable step	€ 292,636 Bank debt 2025: € 292,636 ▼ 9% vs 2024 (€ 323,077) Favourable step	▼ 9%
Balance sheet total	€ 375,287 Balance sheet total 2022: € 375,287 First fiscal year in the series	€ 294,868 Balance sheet total 2023: € 294,868 ▼ 21% vs 2022 (€ 375,287) Unchanged	€ 686,471 Balance sheet total 2024: € 686,471 ▲ 133% vs 2023 (€ 294,868) Unchanged	€ 677,966 Balance sheet total 2025: € 677,966 ▼ 1% vs 2024 (€ 686,471) Unchanged	▼ 1%
Employees (FTE)	0.3 Employees (FTE) 2022: 0.3 First fiscal year in the series	0 Employees (FTE) 2023: 0 ▼ 0.3 vs 2022 (0.3) Unchanged	0 Employees (FTE) 2024: 0 Unchanged (0) Unchanged	0 Employees (FTE) 2025: 0 Unchanged (0) Unchanged

Key figures of APOTHEEK DE LINDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK DE LINDE?

What happened at APOTHEEK DE LINDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 8, 2026 New annual accounts for financial year 2025: profit of € 40,346 (▼ 11% vs 2024). Source: NBB ↗
2018 Charlie BV became a director. NBB
2015 Mapant BV became a director. NBB
Jan 2, 1985 New establishment in Retie. KBO
Dec 21, 1984 Start of the company according to the CBE. KBO

In short

From € 65,020 profit in 2022 to € 40,346 profit in 2025.

Paid € 24,473 in corporate taxes since 2022.

Best year ever: 2023, with € 96,579 profit.

Paid out € 246,300 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

MAPANT 100%

The stake of MAPANT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK DE LINDE

Behind APOTHEEK DE LINDE are Mapant BV and Charlie BV. The shares are held by MAPANT (100%).

Directors

According to the 2025 annual accounts

Mapant BV

Director · represented by Isabelle Bourgeouis

since 2015

Charlie BV

Director · represented by Charlotte Plompen

since 2018

Shareholders

MAPANT

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Markt 2

2470 Retie

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

immo s.v.

€ -2,843 gross margin · 2025

HIZZ

€ -4,690 gross margin · 2025

VERENIGING VAN MEDE-EIGENAARS GEBOUW RETIE MARKT 2

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.637.474

VAT number

BE 0426.637.474

Registered office

Markt 2, 2470 Retie

Names & denominations

APOTHEEK DE LINDE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

21 December 1984

Peppol

Active · Active since 15 Sept 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK DE LINDE

Financials

What happened to APOTHEEK DE LINDE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions